Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Dermatofibrosarcoma × brigimadlin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Liposarcoma 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1

Interventions

indolepropanol phosphate 1 brigimadlin 1 Watchful Waiting 1 Radiotherapy, Conformal 1 Observation 1 Ifosfamide 1 Gemcitabine 1 Doxorubicin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06370871 2024-07-17

Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma

Boehringer Ingelheim

Phase 3 Withdrawn

Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡